Arrowhead Pharmaceuticals, Inc. (ARWR)
USD 15.06
(-0.99%)
USD 15.06
(-0.99%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 115.17 Million USD | 41.18% |
| 2022 | 81.57 Million USD | 219.34% |
| 2021 | 25.54 Million USD | 20.85% |
| 2020 | 21.13 Million USD | 0.0% |
| 2019 | - USD | -100.0% |
| 2018 | 2.32 Million USD | -8.23% |
| 2017 | 2.53 Million USD | -7.12% |
| 2016 | 2.72 Million USD | 259.7% |
| 2015 | 758.34 Thousand USD | -25.82% |
| 2014 | 1.02 Million USD | -55.63% |
| 2013 | 2.3 Million USD | -1.4% |
| 2012 | 2.33 Million USD | 285.09% |
| 2011 | 606.78 Thousand USD | 21.36% |
| 2010 | 500 Thousand USD | -59.23% |
| 2009 | 1.22 Million USD | -20.2% |
| 2008 | 1.53 Million USD | 0.0% |
| 2007 | - USD | -100.0% |
| 2006 | 1.2 Million USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | -100.0% |
| 2002 | 633.5 Thousand USD | 13.33% |
| 2001 | 559 Thousand USD | -0.71% |
| 2000 | 563 Thousand USD | -0.35% |
| 1999 | 565 Thousand USD | -57.72% |
| 1998 | 1.33 Million USD | 30.51% |
| 1997 | 1.02 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 399.85 Million USD | 237.21% |
| 2024 Q1 | 118.57 Million USD | 2.96% |
| 2024 Q3 | 454.12 Million USD | 13.57% |
| 2023 Q2 | 82.78 Million USD | 0.79% |
| 2023 FY | 115.17 Million USD | 41.18% |
| 2023 Q1 | 82.13 Million USD | 0.68% |
| 2023 Q3 | 82.73 Million USD | -0.06% |
| 2023 Q4 | 115.17 Million USD | 39.21% |
| 2022 Q1 | 25.31 Million USD | -0.9% |
| 2022 Q2 | 25.6 Million USD | 1.16% |
| 2022 Q3 | 81.11 Million USD | 216.75% |
| 2022 FY | 81.57 Million USD | 219.34% |
| 2022 Q4 | 81.57 Million USD | 0.57% |
| 2021 Q3 | 24.14 Million USD | 1.45% |
| 2021 Q4 | 25.54 Million USD | 5.8% |
| 2021 FY | 25.54 Million USD | 20.85% |
| 2021 Q1 | 20.86 Million USD | -1.28% |
| 2021 Q2 | 23.8 Million USD | 14.05% |
| 2020 Q2 | 14.86 Million USD | 0.19% |
| 2020 Q3 | 21.37 Million USD | 43.75% |
| 2020 FY | 21.13 Million USD | 0.0% |
| 2020 Q4 | 21.13 Million USD | -1.09% |
| 2020 Q1 | 14.83 Million USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 FY | - USD | -100.0% |
| 2019 Q4 | - USD | 0.0% |
| 2019 Q1 | - USD | -100.0% |
| 2018 Q3 | 2.37 Million USD | -2.16% |
| 2018 Q2 | 2.43 Million USD | -2.08% |
| 2018 Q1 | 2.48 Million USD | -2.0% |
| 2018 FY | 2.32 Million USD | -8.23% |
| 2018 Q4 | 2.32 Million USD | -2.25% |
| 2017 Q2 | 2.63 Million USD | -1.8% |
| 2017 Q4 | 2.53 Million USD | -1.93% |
| 2017 FY | 2.53 Million USD | -7.12% |
| 2017 Q1 | 2.68 Million USD | -1.73% |
| 2017 Q3 | 2.58 Million USD | -1.86% |
| 2016 Q2 | 650.01 Thousand USD | -7.71% |
| 2016 FY | 2.72 Million USD | 259.7% |
| 2016 Q3 | 3.32 Million USD | 411.26% |
| 2016 Q4 | 2.72 Million USD | -17.92% |
| 2016 Q1 | 704.28 Thousand USD | -7.13% |
| 2015 FY | 758.34 Thousand USD | -25.82% |
| 2015 Q1 | 919.16 Thousand USD | -10.09% |
| 2015 Q2 | 865.77 Thousand USD | -5.81% |
| 2015 Q3 | 812.16 Thousand USD | -6.19% |
| 2015 Q4 | 758.34 Thousand USD | -6.63% |
| 2014 Q3 | 1.07 Million USD | -49.47% |
| 2014 FY | 1.02 Million USD | -55.63% |
| 2014 Q1 | 2.27 Million USD | -1.14% |
| 2014 Q2 | 2.12 Million USD | -6.57% |
| 2014 Q4 | 1.02 Million USD | -4.92% |
| 2013 Q3 | 2.31 Million USD | -0.37% |
| 2013 Q4 | 2.3 Million USD | -0.36% |
| 2013 Q1 | 2.42 Million USD | 3.97% |
| 2013 FY | 2.3 Million USD | -1.4% |
| 2013 Q2 | 2.32 Million USD | -4.47% |
| 2012 Q2 | 2.35 Million USD | -0.27% |
| 2012 FY | 2.33 Million USD | 285.09% |
| 2012 Q1 | 2.35 Million USD | 288.38% |
| 2012 Q3 | 2.34 Million USD | -0.29% |
| 2012 Q4 | 2.33 Million USD | -0.29% |
| 2011 Q4 | 606.78 Thousand USD | 8.19% |
| 2011 Q1 | 500 Thousand USD | 0.0% |
| 2011 FY | 606.78 Thousand USD | 21.36% |
| 2011 Q3 | 560.87 Thousand USD | 7.92% |
| 2011 Q2 | 519.71 Thousand USD | 3.94% |
| 2010 Q1 | 1.01 Million USD | -17.36% |
| 2010 FY | 500 Thousand USD | -59.23% |
| 2010 Q4 | 500 Thousand USD | -13.02% |
| 2010 Q3 | 574.84 Thousand USD | -27.82% |
| 2010 Q2 | 796.41 Thousand USD | -21.43% |
| 2009 Q1 | 3.85 Million USD | 150.94% |
| 2009 Q4 | 1.22 Million USD | -14.54% |
| 2009 Q3 | 1.43 Million USD | -60.75% |
| 2009 FY | 1.22 Million USD | -20.2% |
| 2009 Q2 | 3.65 Million USD | -5.2% |
| 2008 Q4 | 1.53 Million USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 FY | 1.53 Million USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2007 Q1 | - USD | -100.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 FY | - USD | -100.0% |
| 2007 Q2 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q4 | 1.2 Million USD | 0.0% |
| 2006 FY | 1.2 Million USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2003 FY | - USD | -100.0% |
| 2003 Q1 | 632 Thousand USD | -0.24% |
| 2003 Q2 | 630.5 Thousand USD | -0.24% |
| 2003 Q3 | 629.5 Thousand USD | -0.16% |
| 2003 Q4 | - USD | -100.0% |
| 2002 Q4 | 633.5 Thousand USD | -0.24% |
| 2002 FY | 633.5 Thousand USD | 13.33% |
| 2002 Q3 | 635 Thousand USD | 18.36% |
| 2002 Q2 | 536.5 Thousand USD | -3.85% |
| 2002 Q1 | 558 Thousand USD | -0.18% |
| 2001 Q1 | 562.5 Thousand USD | -0.09% |
| 2001 FY | 559 Thousand USD | -0.71% |
| 2001 Q3 | 560.5 Thousand USD | -0.27% |
| 2001 Q4 | 559 Thousand USD | -0.27% |
| 2001 Q2 | 562 Thousand USD | -0.09% |
| 2000 Q4 | 563 Thousand USD | -0.09% |
| 2000 Q1 | 564.5 Thousand USD | -5.92% |
| 2000 Q2 | 564 Thousand USD | -0.09% |
| 2000 FY | 563 Thousand USD | -0.35% |
| 2000 Q3 | 563.5 Thousand USD | -0.09% |
| 1999 FY | 565 Thousand USD | -57.72% |
| 1999 Q4 | 600 Thousand USD | 0.0% |
| 1999 Q2 | 1.1 Million USD | 0.0% |
| 1999 Q3 | 600 Thousand USD | -45.45% |
| 1998 Q3 | 1.1 Million USD | 10.0% |
| 1998 Q2 | 1 Million USD | 0.0% |
| 1998 FY | 1.33 Million USD | 30.51% |
| 1998 Q4 | 1.1 Million USD | 0.0% |
| 1997 FY | 1.02 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Tiziana Life Sciences Ltd | 247 Thousand USD | -46527.935% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| SciSparc Ltd. | 76 Thousand USD | -151440.789% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -10.548% |
| Apollomics, Inc. | 4.66 Million USD | -2370.95% |
| 89bio, Inc. | 27.1 Million USD | -324.86% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -19587.35% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -11.238% |
| Immunovant, Inc. | 138 Thousand USD | -83357.246% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -1168.263% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -281.159% |
| Alector, Inc. | 38.91 Million USD | -195.932% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -7306.495% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 95.707% |
| Atai Life Sciences N.V. | 16.47 Million USD | -599.023% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -99.01% |
| Roivant Sciences Ltd. | 499.74 Million USD | 76.954% |
| BioLineRx Ltd. | 11.59 Million USD | -893.624% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 89.843% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -5146.97% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | 38.204% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -62.268% |
| Celularity Inc. | 65.41 Million USD | -76.057% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -7306.495% |
| Coherus BioSciences, Inc. | 480.84 Million USD | 76.048% |
| Clene Inc. | 32.16 Million USD | -258.108% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -24667.957% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -76172.185% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -319.032% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| Generation Bio Co. | 97.89 Million USD | -17.649% |
| ImmunityBio, Inc. | 883.67 Million USD | 86.967% |
| Innoviva, Inc. | 449.07 Million USD | 74.354% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -2032.796% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -697.362% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -839.558% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -140902.693% |
| Ainos, Inc. | 5.96 Million USD | -1831.247% |
| Korro Bio, Inc. | 33.2 Million USD | -246.827% |
| Alkermes plc | 290.73 Million USD | 60.386% |
| MiMedx Group, Inc. | 48.09 Million USD | -139.446% |
| Aptose Biosciences Inc. | 1 Million USD | -11305.26% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -138.8% |
| 180 Life Sciences Corp. | 1.32 Million USD | -8624.62% |
| MacroGenics, Inc. | 33.97 Million USD | -239.027% |
| BioAtla, Inc. | 2.46 Million USD | -4581.748% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -1976.65% |
| MediciNova, Inc. | 215.92 Thousand USD | -53238.181% |
| Benitec Biopharma Inc. | 284 Thousand USD | -40453.169% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -787.569% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -2195.157% |
| Avid Bioservices, Inc. | 207.83 Million USD | 44.585% |
| Celularity Inc. | 65.41 Million USD | -76.057% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -811306.228% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -1220.617% |
| Arcellx, Inc. | 97.62 Million USD | -17.973% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -13843.22% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | 49.802% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Agenus Inc. | 350.24 Million USD | 67.117% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -38.113% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -934.037% |
| Allakos Inc. | 41.46 Million USD | -177.755% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Annexon, Inc. | 31.35 Million USD | -267.313% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -6115.38% |
| Organovo Holdings, Inc. | 1.39 Million USD | -8161.908% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -5562.294% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -9294.046% |
| Aptorum Group Limited | 3.36 Million USD | -3325.265% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -574.298% |
| Aridis Pharmaceuticals, Inc. | 6.13 Million USD | -1778.809% |
| Ardelyx, Inc. | 55.98 Million USD | -105.729% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | 44.069% |
| CorMedix Inc. | 667.63 Thousand USD | -17150.671% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 93.38% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 86.43% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -439.923% |
| BeiGene, Ltd. | 930.18 Million USD | 87.618% |
| bluebird bio, Inc. | 330.32 Million USD | 65.134% |
| Bionomics Limited | 239.61 Million USD | 51.936% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -469.618% |
| Bio-Path Holdings, Inc. | 113 Thousand USD | -101821.239% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -28692.75% |
| Prime Medicine, Inc. | 13.63 Million USD | -744.796% |
| PTC Therapeutics, Inc. | 415.02 Million USD | 72.25% |
| PolyPid Ltd. | 11.77 Million USD | -877.766% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -70854.367% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -13.599% |
| Precision BioSciences, Inc. | 31.26 Million USD | -268.335% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -127.287% |
| CalciMedica, Inc. | - USD | -Infinity% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -442.262% |
| Elevation Oncology, Inc. | 30.13 Million USD | -282.158% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -1565.043% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -2261.513% |
| ChromaDex Corporation | 3.27 Million USD | -3414.525% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -11059.981% |
| Summit Therapeutics Inc. | 106.09 Million USD | -8.551% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -3108.106% |
| Compugen Ltd. | 1.35 Million USD | -8424.87% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -2011.292% |
| Chimerix, Inc. | 2.14 Million USD | -5271.782% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -36.155% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -5256.791% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -451.473% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -724.181% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -311172.973% |
| Daré Bioscience, Inc. | 5.31 Million USD | -2065.624% |
| Dyadic International, Inc. | 136.92 Thousand USD | -84010.013% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -964.329% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -320.102% |
| Eloxx Pharmaceuticals, Inc. | 13.38 Million USD | -760.513% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -11109.969% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -143275.909% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -175.246% |
| Evogene Ltd. | 1.13 Million USD | -10020.475% |
| Exelixis, Inc. | 189.94 Million USD | 39.366% |
| Eyenovia, Inc. | 16.1 Million USD | -615.003% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -2005.888% |
| TRACON Pharmaceuticals, Inc. | 968 Thousand USD | -11797.831% |
| Fortress Biotech, Inc. | 88.59 Million USD | -30.002% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -6492.501% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -101.33% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -685.025% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -155.521% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | 74.122% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 93.136% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -280804.878% |
| Gritstone bio, Inc. | 104.77 Million USD | -9.922% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -25.928% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -1655.923% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -208675.492% |
| Heron Therapeutics, Inc. | 179.62 Million USD | 35.884% |
| Humacyte, Inc. | 58.1 Million USD | -98.208% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -97.613% |
| ImmuCell Corporation | 11.96 Million USD | -862.22% |
| Better Therapeutics, Inc. | 14.88 Million USD | -673.999% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -18416.149% |
| Incyte Corporation | 38.28 Million USD | -200.81% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 82.14% |
| INmune Bio, Inc. | 10.43 Million USD | -1003.488% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -281.244% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -72793.038% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 92.077% |
| Verastem, Inc. | 41.55 Million USD | -177.14% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 98.013% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -4033.92% |
| Kodiak Sciences Inc. | 181.63 Million USD | 36.591% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Kura Oncology, Inc. | 17.2 Million USD | -569.599% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -508.308% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -24146.526% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| ContextLogic Inc. | 6 Million USD | -1819.517% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -1724.347% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | 1.725% |
| Mesoblast Limited | 118.92 Million USD | 3.155% |
| Mustang Bio, Inc. | 2.49 Million USD | -4510.528% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -19964.634% |
| Seres Therapeutics, Inc. | 213.93 Million USD | 46.166% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -122.445% |
| Genelux Corporation | 2.51 Million USD | -4472.092% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 81.149% |
| Molecular Templates, Inc. | 12.23 Million USD | -841.709% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -478.139% |
| Neurogene Inc. | 16.25 Million USD | -608.527% |
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -81006.338% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | 0.152% |
| NextCure, Inc. | 6.6 Million USD | -1643.694% |
| Omeros Corporation | 338.28 Million USD | 65.954% |
| Onconetix, Inc. | 9.88 Million USD | -1065.018% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -36117.296% |
| Opthea Limited | 200.62 Million USD | 42.595% |
| PDS Biotechnology Corporation | 23.85 Million USD | -382.865% |
| Precigen, Inc. | 7.09 Million USD | -1522.812% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | 17.161% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -4516.072% |
| Pulmatrix, Inc. | 8.75 Million USD | -1215.338% |
| Pluri Inc. | 29.61 Million USD | -288.934% |
| Autolus Therapeutics plc | 52.96 Million USD | -117.439% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -359.911% |
| Purple Biotech Ltd. | 351 Thousand USD | -32712.251% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 95.739% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -25461.121% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -30.959% |
| Revance Therapeutics, Inc. | 478.43 Million USD | 75.928% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -1849.718% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -115.41% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -12612.031% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -6944.098% |
| Soligenix, Inc. | 3.49 Million USD | -3195.722% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -10.639% |
| Sorrento Therapeutics, Inc. | 134.5 Million USD | 14.374% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -86.307% |
| Surrozen, Inc. | 3.37 Million USD | -3308.434% |
| Seer, Inc. | 28.25 Million USD | -307.555% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -202.254% |
| Shattuck Labs, Inc. | 4.2 Million USD | -2640.861% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -2006.658% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -154.6% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -113930.693% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -99827.985% |
| TG Therapeutics, Inc. | 110.79 Million USD | -3.95% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -1073.657% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -827.004% |
| Blueprint Medicines Corporation | 774.12 Million USD | 85.122% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -114.439% |
| Calithera Biosciences, Inc. | 1.66 Million USD | -6813.025% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -9040.556% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -9033.104% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -5332.594% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -53718.224% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -584.32% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -4430.724% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -326.717% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Xencor, Inc. | 83.43 Million USD | -38.038% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -8016.35% |
| ZIVO Bioscience, Inc. | 346.34 Thousand USD | -33153.547% |
| Zai Lab Limited | 15.15 Million USD | -660.154% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -151.613% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| Insmed Incorporated | 1.2 Billion USD | 90.434% |
| Century Therapeutics, Inc. | 48.17 Million USD | -139.088% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -153.067% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -36.017% |
| XOMA Corporation | 124.45 Million USD | 7.456% |
| Humacyte, Inc. | 58.1 Million USD | -98.208% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -1330433.734% |
| Ovid Therapeutics Inc. | 46 Million USD | -150.362% |
| Immunome, Inc. | 1.65 Million USD | -6880.061% |
| Immunic, Inc. | 1.33 Million USD | -8533.508% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | 45.193% |
| Rallybio Corporation | 392 Thousand USD | -29280.357% |
| Jaguar Health, Inc. | 35.86 Million USD | -221.168% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -85.535% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -24.599% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -588.369% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -342.234% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -3.825% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -1768.143% |
| Trevena, Inc. | 35.23 Million USD | -226.884% |
| Curis, Inc. | 2.79 Million USD | -4022.083% |
| CRISPR Therapeutics AG | 238.63 Million USD | 51.737% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -4033.92% |
| Cytokinetics, Incorporated | 755.77 Million USD | 84.761% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -767.513% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -32900.287% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -13828.988% |
| Erasca, Inc. | 55.85 Million USD | -106.182% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -35175.182% |
| Fortress Biotech, Inc. | 88.59 Million USD | -30.002% |
| GRI Bio, Inc. | 14 Thousand USD | -822550.0% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -55000.469% |
| IGM Biosciences, Inc. | 40.5 Million USD | -184.331% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -40.424% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -56634.483% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -1157.188% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -1474.019% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -37660.984% |
| PureTech Health plc | 25.51 Million USD | -351.439% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| MeiraGTx Holdings plc | 89.26 Million USD | -29.023% |
| Quantum-Si incorporated | 15.3 Million USD | -652.604% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -1567.695% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -166.791% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -240.44% |
| Royalty Pharma plc | 6.13 Billion USD | 98.123% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 241.28 Thousand USD | -47632.35% |
| Solid Biosciences Inc. | 26.26 Million USD | -338.496% |
| Clearside Biomedical, Inc. | 43 Million USD | -167.833% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -66598.905% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -5259.283% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -303.528% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -262.949% |
| Cue Biopharma, Inc. | 14.69 Million USD | -683.743% |
| Panbela Therapeutics, Inc. | 5.19 Million USD | -2117.385% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -76398.134% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -235568.099% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -1077.858% |
| ProKidney Corp. | 4.41 Million USD | -2509.812% |
| Prothena Corporation plc | 11.83 Million USD | -873.139% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -20284.248% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -265.066% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -1069.011% |
| Structure Therapeutics Inc. | 5.45 Million USD | -2012.066% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -3910.132% |
| Immunocore Holdings plc | 84.03 Million USD | -37.056% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -39663.088% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -22892.675% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -18999.668% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -195.917% |
| Turnstone Biologics Corp. | 3.21 Million USD | -3483.416% |
| 2seventy bio, Inc. | 256.67 Million USD | 55.129% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -912.759% |
| Vaxxinity, Inc. | 15.16 Million USD | -659.302% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -447.183% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -6867.393% |
| Statera Biopharma, Inc. | 16.26 Million USD | -608.259% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -169.305% |
| Acelyrin, Inc. | 1.19 Million USD | -9545.812% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -276.204% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -38199.181% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -182711.111% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 3.13 Million USD | -3573.6% |
| FibroGen, Inc. | 170.45 Million USD | 32.433% |
| MediWound Ltd. | 6.71 Million USD | -1616.153% |
| Senti Biosciences, Inc. | 37.66 Million USD | -205.769% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -16962.37% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -4817.635% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -4694.796% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -5290.768% |
| Genprex, Inc. | - USD | -Infinity% |
| IO Biotech, Inc. | 2.49 Million USD | -4517.923% |
| OmniAb, Inc. | 25.56 Million USD | -350.573% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -3612.798% |
| Veracyte, Inc. | 12.63 Million USD | -811.884% |
| Vor Biopharma Inc. | 35.66 Million USD | -222.97% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -820.926% |
| NLS Pharmaceutics AG | 1.63 Million USD | -6949.505% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -21.078% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -17.995% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -166.803% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -334.394% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -70140.353% |
| UroGen Pharma Ltd. | 100.21 Million USD | -14.925% |
| Sutro Biopharma, Inc. | 182.74 Million USD | 36.979% |
| Entera Bio Ltd. | 390 Thousand USD | -29431.026% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | 49.749% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -1585.018% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Novavax, Inc. | 280.63 Million USD | 58.961% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -11736.691% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -223.921% |
| Viracta Therapeutics, Inc. | 25.55 Million USD | -350.661% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -29280.207% |
| Histogen Inc. | 4.62 Million USD | -2391.8% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -70140.353% |
| Portage Biotech Inc. | 47 Thousand USD | -244944.681% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -9033.104% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -82.328% |
| OncoCyte Corporation | 2.86 Million USD | -3914.326% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -8764.654% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -539342.623% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -2618.22% |
| Amarin Corporation plc | 8.73 Million USD | -1218.198% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -2033.982% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -2101.701% |
| NLS Pharmaceutics AG | 1.63 Million USD | -6949.505% |
| Savara Inc. | 26.73 Million USD | -330.739% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -951.31% |
| Bicycle Therapeutics plc | 44.95 Million USD | -156.186% |
| Kiromic BioPharma, Inc. | 15.54 Million USD | -641.007% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -9993.865% |
| Aura Biosciences, Inc. | 19.55 Million USD | -488.899% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -56381.014% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Galecto, Inc. | 249 Thousand USD | -46153.414% |
| XBiotech Inc. | - USD | -Infinity% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -328.448% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -356.394% |
| NexImmune, Inc. | 68.8 Thousand USD | -167277.814% |
| Imunon, Inc. | 1.62 Million USD | -6988.694% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -510.89% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Travere Therapeutics, Inc. | 404.78 Million USD | 71.548% |
| GT Biopharma, Inc. | 58 Thousand USD | -198470.69% |
| Adagene Inc. | 22.3 Million USD | -416.303% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -4.361% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -467.541% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -731.56% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -34906.383% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -355.257% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -3268339.977% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -1404.049% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -60.39% |
| ADMA Biologics, Inc. | 141.41 Million USD | 18.56% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -4598.947% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -177086.154% |
| Biomea Fusion, Inc. | 10.29 Million USD | -1018.599% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -1952.171% |
| Mereo BioPharma Group plc | 5.95 Million USD | -1834.997% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -23831.885% |
| Absci Corporation | 15.95 Million USD | -621.758% |
| aTyr Pharma, Inc. | 15.09 Million USD | -662.974% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -569.716% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -6958.236% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 92.318% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| Orgenesis Inc. | 22.62 Million USD | -409.133% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -2398.828% |
| GH Research PLC | 343 Thousand USD | -33477.551% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -1672.953% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Replimune Group, Inc. | 75.86 Million USD | -51.802% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -9307.658% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -1124.702% |
| Kronos Bio, Inc. | 28.27 Million USD | -307.368% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -68.798% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -4665.039% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -3545.806% |
| scPharmaceuticals Inc. | 40.26 Million USD | -186.004% |
| HilleVax, Inc. | 51.19 Million USD | -124.974% |
| Tharimmune, Inc. | - USD | -Infinity% |
| AlloVir, Inc. | 27.42 Million USD | -319.888% |
| Kineta, Inc. | 1.31 Million USD | -8644.951% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -3137.869% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Codexis, Inc. | 22.36 Million USD | -414.984% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -122.647% |
| Cibus, Inc. | 24.62 Million USD | -367.775% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -29970.757% |
| DBV Technologies S.A. | 14.38 Million USD | -700.855% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -53.488% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -2850.833% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Peak Bio, Inc. | 10.72 Million USD | -974.175% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -4503.157% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -1755.203% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -6726.971% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -3.302% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -2379.996% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -150.16% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -258.587% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -11592.487% |
| Adicet Bio, Inc. | 20.92 Million USD | -450.425% |
| Moolec Science SA | 2.64 Million USD | -4253.815% |
| Aditxt, Inc. | 18.21 Million USD | -532.183% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Geron Corporation | 85.89 Million USD | -34.077% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -652.604% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -14146.749% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -8507.698% |
| Notable Labs, Ltd. | 2.04 Million USD | -5520.839% |
| Liquidia Corporation | 3.5 Million USD | -3187.782% |
| Vericel Corporation | 88.14 Million USD | -30.664% |
| Invivyd, Inc. | 2.16 Million USD | -5219.677% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Vaxcyte, Inc. | 29.22 Million USD | -294.097% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -90.117% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -457.432% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -28478.412% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | 40.385% |
| PepGen Inc. | 20.1 Million USD | -472.876% |
| United Therapeutics Corporation | 700 Million USD | 83.547% |
| Finch Therapeutics Group, Inc. | 30.12 Million USD | -282.298% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 886 Thousand USD | -12898.984% |
| Pharming Group N.V. | 171.54 Million USD | 32.863% |
| XOMA Corporation | 124.45 Million USD | 7.456% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -1977.774% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| AbCellera Biologics Inc. | 77.38 Million USD | -48.838% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 3.37 Million USD | -3308.434% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -369.281% |
| Vir Biotechnology, Inc. | 124.54 Million USD | 7.523% |
| Evaxion Biotech A/S | 10.86 Million USD | -959.562% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -1168.263% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -53.752% |
| BioVie Inc. | 6.11 Million USD | -1784.513% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -51246.857% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -49019.507% |
| eFFECTOR Therapeutics, Inc. | 19.44 Million USD | -492.291% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -36.208% |
| Celcuity Inc. | 37.44 Million USD | -207.563% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -304.293% |
| IN8bio, Inc. | 4.89 Million USD | -2253.791% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -8.586% |
| Instil Bio, Inc. | 86.05 Million USD | -33.836% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -140902.693% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -956.324% |
| Immuneering Corporation | 4.46 Million USD | -2480.597% |
| Verona Pharma plc | 51.32 Million USD | -124.378% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -767.513% |
| uniQure N.V. | 138.4 Million USD | 16.789% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -905.246% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -34.824% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -766.86% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -2654.628% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -54615.923% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -41933.212% |
| Zura Bio Limited | - USD | -Infinity% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -11592.487% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -6545.759% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -31715.193% |
| Altimmune, Inc. | 671 Thousand USD | -17064.083% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -1539.678% |
| Moolec Science SA | 2.64 Million USD | -4253.815% |
| Lumos Pharma, Inc. | 6.58 Million USD | -1648.99% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -1077.858% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -478.139% |
| Nutriband Inc. | 241.28 Thousand USD | -47632.35% |
| argenx SE | 20 Million USD | -475.855% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -27652.048% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | 62.624% |
| NeurAxis, Inc. | 224.26 Thousand USD | -51256.015% |
| CervoMed Inc. | - USD | -Infinity% |
| AnaptysBio, Inc. | 17.81 Million USD | -546.52% |
| Design Therapeutics, Inc. | 3.05 Million USD | -3676.098% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -43858.397% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -709.467% |
| Achilles Therapeutics plc | 4.61 Million USD | -2395.58% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -1027.69% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | 69.183% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -282.641% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -3014.526% |
| Palisade Bio, Inc. | 369 Thousand USD | -31111.653% |
| Beam Therapeutics Inc. | 173.17 Million USD | 33.494% |
| AEON Biopharma, Inc. | 278 Thousand USD | -41328.417% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -34279.403% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -107646.209% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -51.816% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -88.474% |
| Athira Pharma, Inc. | 1.58 Million USD | -7166.309% |
| Vaccinex, Inc. | 247 Thousand USD | -46527.935% |
| HCW Biologics Inc. | 6.45 Million USD | -1685.105% |
| XOMA Corporation | 124.45 Million USD | 7.456% |
| Nektar Therapeutics | 230.4 Million USD | 50.013% |
| Arvinas, Inc. | 3.4 Million USD | -3287.382% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -6958.236% |
| Merus N.V. | 12.16 Million USD | -846.974% |
| Omega Therapeutics, Inc. | 128.42 Million USD | 10.323% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -733.727% |
| Rezolute, Inc. | 2.22 Million USD | -5069.255% |
| Clene Inc. | 32.16 Million USD | -258.108% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -65692.074% |
| BeyondSpring Inc. | 3.99 Million USD | -2782.879% |
| Synlogic, Inc. | 17.27 Million USD | -566.692% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -8759.308% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -328960.0% |
| Peak Bio, Inc. | 10.72 Million USD | -974.175% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -121.811% |
| Krystal Biotech, Inc. | 8.09 Million USD | -1322.918% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | 34.938% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -1532.011% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -84216.295% |
| MannKind Corporation | 382.37 Million USD | 69.88% |
| Ikena Oncology, Inc. | 10.73 Million USD | -972.555% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -28059.169% |
| Gossamer Bio, Inc. | 212.46 Million USD | 45.793% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -66090.23% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -1157.188% |
| Legend Biotech Corporation | 328.67 Million USD | 64.959% |
| Mural Oncology plc | 15 Million USD | -667.346% |
| Biora Therapeutics, Inc. | 47.42 Million USD | -142.844% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 2.1 Million USD | -5381.723% |
| Champions Oncology, Inc. | 7.43 Million USD | -1450.081% |
| REGENXBIO Inc. | 89.29 Million USD | -28.985% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -13375.068% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -20727.26% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -2027.281% |
| Vaxart, Inc. | 26.51 Million USD | -334.378% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -635.571% |
| Cellectis S.A. | 92.85 Million USD | -24.036% |
| Longeveron Inc. | 2.04 Million USD | -5542.871% |
| Repare Therapeutics Inc. | 3.41 Million USD | -3277.449% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 91.755% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -147.191% |
| Revolution Medicines, Inc. | 87.94 Million USD | -30.959% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -66472.832% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -2813.509% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -36231.546% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -65712.0% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 85.753% |
| Denali Therapeutics Inc. | 52.24 Million USD | -120.461% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -699.495% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -8282.169% |
| Cingulate Inc. | 3.13 Million USD | -3573.6% |
| Passage Bio, Inc. | 26.29 Million USD | -338.012% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -1627.997% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -28128.186% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -12782.662% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -460.143% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -9040.556% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -4598.707% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -3587.832% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -14101.11% |
| OmniAb, Inc. | 25.56 Million USD | -350.573% |
| Anew Medical, Inc. | 1.6 Million USD | -7075.763% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -289.317% |
| Lipocine Inc. | 17.16 Thousand USD | -670825.084% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -889.612% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -232.595% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -1849.718% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -101.443% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -56634.483% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -2129.835% |
| Ocugen, Inc. | 6.94 Million USD | -1559.285% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -715.139% |
| Q32 Bio Inc. | 1.31 Million USD | -8638.316% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -17038.542% |
| Alumis Inc. Common Stock | 32.58 Million USD | -253.502% |
| Equillium, Inc. | 824 Thousand USD | -13877.063% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -1168.543% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -38187.468% |
| Galera Therapeutics, Inc. | 152.29 Million USD | 24.378% |
| Evelo Biosciences, Inc. | 51.13 Million USD | -125.216% |
| Comera Life Sciences Holdings, Inc. | 775.04 Thousand USD | -14759.854% |
| Dominari Holdings Inc. | 3.02 Million USD | -3703.534% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -121790.842% |
| vTv Therapeutics Inc. | 529 Thousand USD | -21671.456% |
| Bio-Techne Corporation | 419.53 Million USD | 72.548% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -59.969% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | 40.5% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -581.969% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -405.979% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -1801.139% |
| Nkarta, Inc. | 88.33 Million USD | -30.374% |
| BioCardia, Inc. | 1.31 Million USD | -8658.251% |
| Iterum Therapeutics plc | 19.5 Million USD | -490.348% |